Skip to main content

BPH

0
Pipeline Programs
8
Companies
6
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

6 companies ranked by most advanced pipeline stage

Butterfly Biosciences
Butterfly BiosciencesCA - Marina del Rey
2 programs
Butterfly Medical Prostatic Retraction DeviceN/A1 trial
Butterfly device implantationN/A1 trial
Active Trials
NCT05330520Recruiting60Est. Feb 2027
NCT03912558Completed92Est. Apr 2024
Butterfly Medical
Butterfly MedicalIsrael - Yokneam
2 programs
Butterfly Medical Prostatic Retraction DeviceN/A
Butterfly device implantationN/A
Procept BioRobotics
Procept BioRoboticsCA - San Jose
1 program
AquablationN/A1 trial
Active Trials
NCT02974751Unknown178Est. Feb 2020
Hanmi Pharmaceutical
1 program
Hanmi Tams® CapsuleN/A1 trial
Active Trials
NCT05422677Completed4,698Est. Aug 2021
Terumo Medical
Terumo MedicalGermany - Leverkusen
1 program
Prostatic Artery EmbolizationN/A1 trial
Active Trials
NCT04398966Terminated12Est. May 2023
Ferring Pharmaceuticals
Ferring PharmaceuticalsArgentina - Buenos Aires
1 program
DegarelixPHASE_21 trial
Active Trials
NCT00527488Completed52Est. May 2009

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Ferring PharmaceuticalsDegarelix
Butterfly BiosciencesButterfly Medical Prostatic Retraction Device
Terumo MedicalProstatic Artery Embolization
Hanmi PharmaceuticalHanmi Tams® Capsule
Butterfly BiosciencesButterfly device implantation
Procept BioRoboticsAquablation

Clinical Trials (6)

Total enrollment: 5,092 patients across 6 trials

NCT00527488Ferring PharmaceuticalsDegarelix

Explorative Study of Degarelix for Treatment of Benign Prostatic Hyperplasia.

Start: Oct 2007Est. completion: May 200952 patients
Phase 2Completed
NCT05330520Butterfly BiosciencesButterfly Medical Prostatic Retraction Device

Long Term Safety and Efficacy of Butterfly Medical Prostatic Retraction Device in Benign Prostatic Hyperplasia (BPH) Patients Who Completed 12 Months of Follow-Up Post Implantation (Continuation Study for Study BM-011-IL)

Start: Feb 2021Est. completion: Feb 202760 patients
N/ARecruiting
NCT04398966Terumo MedicalProstatic Artery Embolization

Prostatic Artery Embolization vs Medication for Benign Prostatic Hyperplasia

Start: Sep 2020Est. completion: May 202312 patients
N/ATerminated
NCT05422677Hanmi PharmaceuticalHanmi Tams® Capsule

An Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia

Start: Jul 2019Est. completion: Aug 20214,698 patients
N/ACompleted
NCT03912558Butterfly BiosciencesButterfly device implantation

Pilot Study to Assess the Safety and Efficacy of Butterfly Medical Prostatic Retraction Device in BPH Patients.

Start: Oct 2018Est. completion: Apr 202492 patients
N/ACompleted
NCT02974751Procept BioRoboticsAquablation

Global Post-Market Registry Using Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue

Start: Sep 2017Est. completion: Feb 2020178 patients
N/AUnknown

Related Jobs

Senior Manager, Global Logistics

Procept BioRoboticsProcept BioRobotics
San Jose, CA
3d ago
$169K - $199K/yr

Senior Manufacturing Engineer (Laser Welding)

Procept BioRoboticsProcept BioRobotics
San Jose, CA (Hybrid)
3d ago
$131K - $154K/yr

Senior Equipment Engineer

Procept BioRoboticsProcept BioRobotics
San Jose, CA
3d ago
$132K - $154K/yr

Territory Development Representative - New England

Procept BioRoboticsProcept BioRobotics
Remote
3d ago
$85K/yr

Clinical Specialist - Tallahassee, FL

Procept BioRoboticsProcept BioRobotics
Remote
4d ago
From $108K/yr

Senior Territory Manager- Wichita/ Kansas City

Procept BioRoboticsProcept BioRobotics
Remote
4d ago
$120K/yr

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 5,092 patients
8 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.